Welcome to the Barts Cancer Institute Preclinical Imaging Facility at Queen Mary University of London. We house a wide range of imaging equipment, offering affordable and accessible in vivo imaging solutions.
Our facilities include a fully equipped radiochemistry laboratory where our expert staff can assist in developing custom-targeted imaging agents for PET and SPECT or molecular radiotherapy agents. We have a strong commitment to promoting the 3Rs’ advantages of imaging for reduction of animal numbers and refinement of procedures.
While we specialize in cancer research, our capabilities extend beyond oncology, and we can help design imaging studies for various disease models. We routinely handle applications such as tumour screening for early detection and size-matched inclusion in studies, assessment of therapy response, reporter gene imaging, receptor-targeted imaging, and imaging of hard-to-assess cancers, including orthotopic and spontaneous models (e.g., pancreatic, lung, brain, ovarian) and metastatic models. Additionally, we can assist with a broad range of other disease models, including those related to infection and inflammation, neurology, trauma and healing, bone and dental research, and cardiovascular applications.



